Medicine Information

Bextra Withdrawal Could Be Just the Beginning for Pfizer


The pharmaceutical industry is a tremendously profitable one, as anyone who reads the business pages of their newspaper can see. Although it can take years to develop a new drug and bring it to market, the profits obtained from a breakthrough drug can be staggering. Last year Merck sold about $2.5 billion worth of Vioxx, and Pfizer sold about $1.3 billion worth of Bextra. The profits are huge, but so are the losses if a problem should develop with a pharmaceutical product. Pfizer voluntarily withdrew the popular anti-inflammatory drug Bextra from the market last month, and their stock has suffered from both the loss of sales and the potential for a large number of product liability lawsuits. Pfizer may have to endure a double whammy this year as the FDA announced that they are investigating reports that the impotence drug Viagra may be linked to cases of blindness in male users. Cialis and Levitra were also mentioned in the report, although most of the cases involved the use of Viagra.

The FDA reports shouldn't cause alarm; the agency says that it is investigating fewer than 50 incidents of blindness in patients who use a drug that has been used by more than twenty million people since its introduction seven years ago. The FDA investigation says less about the likelihood of blindness in patients than it does about the agency's own concerns about its reputation. The FDA rightly insists upon rigorous testing of drugs before they reach the market in the name of public safety. But that coin has two sides, and there are those who say that the agency is too quick to approve potentially dangerous drugs and others who say that the agency's testing isn't thorough enough. Adding fuel to the fire are the recent memos obtained from Merck employees that suggest that the company was aggressively marketing Vioxx even though their sales staff knew the drug was potentially dangerous.

There may be no link between Viagra and blindness at all, as the form of sudden blindness alleged to have been caused by Viagra use is common to the sorts of patients who have erectile disfunction. The FDA is just being cautious, as they should be. Further tests will determine if there is an actual link. The party likely to suffer immediately is Pfizer, as stockholders, already concerned about Bextra lawsuits, drove the stock price lower immediately upon the release of the Viagra news. Sales will probably decrease, too, as patients who are now accustomed to reading about drugs being withdrawn from the market may shy away from the product until further tests are done. That could present a huge income for Pfizer, as they currently sell about $2 billion worth of Viagra each year. The drug business is a profitable one, but like any business, comes with risks. This year, it would seem that Pfizer is getting a double dose of bad medicine.

©Copyright 2005 by Retro Marketing. Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:

FOXSports.com

WVU: Huggins' fall blamed on taking medicine on empty stomach
USA Today
West Virginia University announced Friday that Bob Huggins' fall in a Las Vegas hotel room last week happened after the coach took medication on an empty ...
Huggins' fall blamed on medicine, empty stomachUSA Today

all 51 news articles »


Apple Insider

Stanford School of Medicine equipping students with Apple's iPad
Apple Insider
The School of Medicine at Stanford University has adopted Apple's iPad, providing the device to all incoming first year medical ...

and more »


Traditional Chinese medicine passes to foreign "heirs"
Xinhua
NANJING, July 31 (Xinhua) -- In an east China traditional Chinese medicine (TCM) hospital, Briton Kate Steiner is watching a ...

and more »


Westminster Student attends Cornell Summer Vet Medicine Program
MiamiHerald.com
... a Westminster Christian School senior was selected to attend the Summer College Program for Veterinary Medicine at Cornell University in Ithaca, ...

and more »


City Town Info Education Channel

Pre-Med Students At Mount Sinai School Of Medicine Do Not Take The MCAT But ...
City Town Info Education Channel
However, according to The Wall Street Journal, a select group of students at Mount Sinai School of Medicine in New York can pursue their dreams of becoming ...
Mt. Sinai Program Lets Some Pre-Meds Swap Orgo for ShakespeareWall Street Journal (blog)
Challenging Traditional Premedical Requirements as Predictors of Success in ...TechCombo (blog)
A Different Path to Medical SchoolNew York Times (blog)
NBC New York -FierceHealthcare -HULIQ
all 21 news articles »


Pharmacists' group says Aetna, CVS Caremark deal is bad medicine
IFAwebnews.com
CVS Caremark has been awarded a 12-year contract to provide pharmacy benefits to the 9.7 million lives covered by Aetna. ...

and more »


A Baker's Dozen Feel-Good Movies – Good Medicine for You!
Moviematics
Marketing data confirm what every stay-at-home viewer already suspected: The majority of Americans will invest time and money going out to a movie only for ...

and more »


“Indian Systems of Medicine practitioners can also practice modern medicine”
The Hindu
Such registration of the practitioners should be with the Tamil Nadu Siddha Medical Council, Tamil Nadu Board of Indian Medicine and Tamil Nadu Homoeopathy ...
'Siddh, Ayurved docs can practice modern medicine'Zee News
Unani and ayurveda docs can conduct surgery: Madras HCTimes of India
No action against genuine doctors: HCExpress Buzz

all 4 news articles »


The Star-Ledger - NJ.com

Novartis To Give Away New Children's Medicine
RTT News
(RTTNews) - The drug company Novartis is distributing 250000 bottles of a medication to take advantage of a product recall in a competing product by Tylenol ...
A Novartis Giveaway of MedicineNew York Times
New fever medicine offered for childrenWLBT-TV
Free Triaminic offerWAVY-TV
Portfolio.com (blog) -PRWeek -Wall Street Journal (blog)
all 20 news articles »


1st high school stem cell curriculum offered
San Francisco Chronicle
With that in mind, the California Institute for Regenerative Medicine has developed the country's first high-school stem cell curriculum, which will be ...

and more »

Google News

home | site map
©EmptyNestNow.com 2006